| 1 |
35354667 | Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes. | 2022 May 10 |
1 |
| 2 |
34219361 | PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. | 2021 Nov |
1 |
| 3 |
32015419 | Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective. | 2020 Feb 3 |
1 |
| 4 |
32329963 | Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. | 2020 Nov |
1 |
| 5 |
31481505 | Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. | 2019 Dec 15 |
1 |
| 6 |
29414995 | The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study. | 2018 |
1 |
| 7 |
29487991 | Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial. | 2018 Sep |
1 |
| 8 |
28867378 | Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection. | 2017 Oct 28 |
3 |
| 9 |
28912917 | The Low-Dose (7.5 mg/day) Pioglitazone Therapy. | 2017 Oct |
1 |
| 10 |
26822630 | Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus. | 2016 Mar |
3 |
| 11 |
26984187 | Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. | 2016 Apr |
1 |
| 12 |
27585671 | Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance. | 2016 Dec |
1 |
| 13 |
25469280 | Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study. | 2015 Jan |
2 |
| 14 |
25607338 | The comparative effect of pioglitazone and metformin on serum osteoprotegerin, adiponectin and intercellular adhesion molecule concentrations in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. | 2015 May |
1 |
| 15 |
25959529 | Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome. | 2015 Oct |
1 |
| 16 |
24705615 | Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. | 2014 Jun |
2 |
| 17 |
25092992 | Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. | 2014 |
2 |
| 18 |
25118999 | Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes. | 2014 Oct |
1 |
| 19 |
25405601 | Adiponectin gene polymorphism rs2241766 T/G is associated with response to pioglitazone treatment in type 2 diabetic patients from southern China. | 2014 |
4 |
| 20 |
23142017 | Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes. | 2013 Jan |
3 |
| 21 |
23439381 | High-resolution identification of human adiponectin oligomers and regulation by pioglitazone in type 2 diabetic patients. | 2013 Jun 15 |
3 |
| 22 |
23524525 | Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin. | 2013 Sep |
1 |
| 23 |
23958241 | Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. | 2013 Nov |
1 |
| 24 |
24482963 | Regulation of adiponectin secretion in human subcutaneous and omental adipose tissue: effects of pioglitazone and endothelin-1: a pilot study. | 2013 Apr |
2 |
| 25 |
21950726 | Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance. | 2012 Mar |
1 |
| 26 |
22072742 | Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. | 2012 Jan |
3 |
| 27 |
22187345 | Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus. | 2012 May |
1 |
| 28 |
22309242 | Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation. | 2012 Aug 1 |
2 |
| 29 |
22334369 | Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin. | 2012 Aug |
1 |
| 30 |
22361751 | Effect of pioglitazone on arterial baroreflex sensitivity and sympathetic nerve activity in patients with acute myocardial infarction and type 2 diabetes mellitus. | 2012 Jun |
1 |
| 31 |
22687642 | The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes. | 2012 Jul |
2 |
| 32 |
25755455 | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 Dec |
1 |
| 33 |
20959530 | Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. | 2011 Jan |
1 |
| 34 |
20961967 | Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. | 2011 Jan |
2 |
| 35 |
21143189 | Low-serum culture system improves the adipogenic ability of visceral adipose tissue-derived stromal cells. | 2011 Jun |
1 |
| 36 |
21255215 | Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial. | 2011 May |
1 |
| 37 |
21498915 | Comparison of metabolic profile and adiponectin level with pioglitazone versus voglibose in patients with type-2 diabetes mellitus associated with metabolic syndrome. | 2011 |
4 |
| 38 |
21590648 | Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load. | 2011 Jun |
1 |
| 39 |
21660077 | Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. | 2011 Dec |
2 |
| 40 |
21756323 | Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study. | 2011 Jul 14 |
1 |
| 41 |
22029000 | Pioglitazone: Indian perspective. | 2011 Oct |
1 |
| 42 |
19577936 | Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes. | 2010 Sep-Oct |
2 |
| 43 |
19875376 | Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients. | 2010 Mar |
1 |
| 44 |
20160397 | Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes. | 2010 |
2 |
| 45 |
20197197 | Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes. | 2010 Jun |
1 |
| 46 |
20221981 | Measurement of adiponectin production from differentiated metabolic stem cells. | 2010 May |
1 |
| 47 |
20415685 | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 May |
1 |
| 48 |
20540652 | Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis. | 2010 Jul |
1 |
| 49 |
20560108 | Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients. | 2010 Aug |
1 |
| 50 |
20590748 | Effect of pioglitazone on endothelial function in impaired glucose tolerance. | 2010 Aug |
2 |